Fig. 5

Analysis of CHSY3 expression on the benefits of immunotherapy. Correlation of IPS with CHSY3 expression (A–D). Correlation of CHSY3 expression with TIDE, dysfunction, exclusion, MSI in TCGA (E–H), GSE26901 (I–L), GSE84433 (M–P), GSE66229 (Q–T) datasets. Submap analysis of CHSY3 expression in relation to the sensitivity of anti-PD1 treatment and anti-CTLA4 treatment (U–X). *P < 0.05; **P < 0.01; ***P < 0.001